AGP Picks
View all

Africa News Observer
Provided by AGP

Africa News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Observer.

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

October 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on October 16, 2026

Technology Drives the Future of Travel: JETOUR Continues to Expand Its 'Travel+' Ecosystem
9 hours ago

Technology Drives the Future of Travel: JETOUR Continues to Expand Its 'Travel+' Ecosystem

Indeterminate EIN Presswire
Henan Mission Machinery Launches Integrated Destoner Suite for Complete Stone Removal and Dust Control
9 hours ago

Henan Mission Machinery Launches Integrated Destoner Suite for Complete Stone Removal and Dust Control

Indeterminate EIN Presswire
Houston’s 2025 $42.9B Real Estate Market: Umar Ali of Owth & Mophet Construction
10 hours ago

Houston’s 2025 $42.9B Real Estate Market: Umar Ali of Owth & Mophet Construction

Indeterminate EIN Presswire
Exiro Nickel Completes Acquisition of Thompson Operations, Launches New Chapter for Northern Manitoba Mining
2 hours ago

Exiro Nickel Completes Acquisition of Thompson Operations, Launches New Chapter for Northern Manitoba Mining

Indeterminate GlobeNewswire
NeOnc’s Boldest Test Yet: Child’s Early Improvement Puts NEO100 in the Spotlight with Compassionate-Use Milestone
2 hours ago

NeOnc’s Boldest Test Yet: Child’s Early Improvement Puts NEO100 in the Spotlight with Compassionate-Use Milestone

Indeterminate GlobeNewswire
Aprea Therapeutics to Host Pre-ESMO Virtual Panel on the State of WEE1 Inhibition in Precision Oncology
3 hours ago

Aprea Therapeutics to Host Pre-ESMO Virtual Panel on the State of WEE1 Inhibition in Precision Oncology

Indeterminate GlobeNewswire
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
4 hours ago

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Tango Therapeutics to Present Updated Vopimetostat + RAS(ON) Combination Data at European Society For Medical Oncology (ESMO) Congress 2026
4 hours ago

Tango Therapeutics to Present Updated Vopimetostat + RAS(ON) Combination Data at European Society For Medical Oncology (ESMO) Congress 2026

Indeterminate GlobeNewswire
Adial Pharmaceuticals Appoints David Rubenstein, M.D., Ph.D., as Chief Scientist to Advance its Colon-Targeted AhR Agonist, AT177, for Ulcerative Colitis
4 hours ago

Adial Pharmaceuticals Appoints David Rubenstein, M.D., Ph.D., as Chief Scientist to Advance its Colon-Targeted AhR Agonist, AT177, for Ulcerative Colitis

Indeterminate GlobeNewswire
San Lorenzo Announces Private Placement of Up to $40 Million
4 hours ago

San Lorenzo Announces Private Placement of Up to $40 Million

Indeterminate GlobeNewswire
MEXC Releases October 2026 Proof of Reserves, Reinforcing User Trust Through Verifiable Transparency
5 hours ago

MEXC Releases October 2026 Proof of Reserves, Reinforcing User Trust Through Verifiable Transparency

Indeterminate GlobeNewswire
Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Enrolls First Patient in Phase Ib/II Combination Trial in Metastatic Colorectal Cancer
10 hours ago

Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Enrolls First Patient in Phase Ib/II Combination Trial in Metastatic Colorectal Cancer

Indeterminate GlobeNewswire
Paladin Announces Availability of Notice of Meeting for Annual General Meeting
13 hours ago

Paladin Announces Availability of Notice of Meeting for Annual General Meeting

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Africa News Observer

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.